Winner of
Computerworld Honors 2009
A European multidisciplinary network for the fight against HIV drug resistance
The EuResist Integrated Database
with data of more than 105.000 HIV patients is open for research studies.
They talk about us
An algorithm for Africa
EuCARE kick-off project on TV
EuCARE: partito lo studio internazionale sul ruolo della scuola durante la pandemia
19 June 2022
Il Metodo Lolli già applicato in 3 istituti a Lodi e Lecce
Audible by Rai GR Parlamento:
15 May 2022
Covid, al via un progetto per analizzare l’effettivo contagio nelle scuole
2 June 2022
Da settembre lo studio di EuCARE. Sotto la lente anche l'impatto psicologico delle restrizioni e l'eventuale perdita di apprendimento a esse associata.
Covid, nelle scuole italiane arriva il progetto europeo ‘Eucare’
1 June 2022
Si tratta di uno studio scientifico internazionale per adottare le migliori pratiche per tutelare tutti gli studenti in queste nuove fasi della pandemia
Audible by Radio Radicale:
9 November 2021
12 May 2023
Contemporary events will be held in Italy, Portugal and Mexico to present the results of the EUCARE SCHOOLS study and local partnerships. The hybrid events will see the participation of local authorities, schools’ principals, teachers and students from the involved schools, together with scientists from the EuCARE project.
A shared online and local session will allow the communities involved in the three countries to get to know each other and share their experiences.
EuCARE annual meeting in Lisbon
15-16 September 2022
Representatives of all project partners from Europe and Brazil gathered in the Portuguese capital to share the results obtained in the first eleven months of the project and to decide how to face future challenges.
Hosted by the Instituto de Higiene e Medicina Tropical, in an atmosphere of excellent collaboration, everyone actively participated in the plenary session and especially in the parallel sessions that allowed a more focused discussion and analysis of the project's activities.
Coordinated by EuResist Network, EuCARE will start its second year of activity in October in a completely changed context. Achieving the project's scientific objectives by adapting to the continuous changes of the epidemics is the challenge that the whole consortium has accepted with enthusiasm. We look forward to seeing each other again but for the moment a special thanks to the entire organizational team and to all the participants who made this meeting particularly fruitful both from a scientific and a human point of view.
23rd Arevir meeting hosts EuCARE
28 April 2023
The 23rd Arevir Meeting will host a special session dedicated to the EuCARE Project. for the second consecutive year.
This session, chaired by Francesca Incardona and Thomas Lengauer, will see the participation of the EuCARE scientists leading the main research activities.
The preliminary results coming from the ongoing studies will be presented as well as the next steps to answer the new challenges from pandemics.
MDR Pathways poster at HIV & Hep meeting 2022
8-10 June 2022
The poster: "Analysis of mutational history of multi-drug resistance with a mutagenetic tree model" by Martin Pirkl et al. from the EuResist MDR Pathways project will be presented at the next European Meeting on HIV & Hepatitis 2022 in Paris.
EuCARE workshop at the 22nd Arevir- EuResist Meeting
6-7 May 2022
The workshop on COVID-19 organised within the 22nd Arevir-EuResist Meeting will be focused on EuCARE as a European-project for the investigation of SARS-CoV-2 and epidemics.
Chaired by Francesca Incardona (EuResist) who coordinates the project, Maurizio Zazzi (Università di Siena) and Anders Sönnerborg (Karolinska Institutet), this session will see the participation of Mr. Jan Paehler, EC RTD, Policy Officer. The EuCARE Management Board Members will present the results already achieved in the first six months of the project and the next steps.
The 22nd Arevir- EuResist Meeting (Cologne, 06-07 May 2022) will also cover a broad range of current topics on viral resistance research pertaining to multiple pathogens such as HIV, HCV, HBV and M. Tuberculi.
.jpg)
The article "Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe" is now published online. Results from a cohort of over 13.000 INSTI experienced individuals in Europe.
Thanks to all the INTEGRATE working group!
We have been pleased to host in Rome the kick-off meeting of the project EuCARE European Cohorts of Patients and Schools to Advance Response to Epidemics funded by the EC under HORIZON-HLTH-2021-CORONA-01
Coordinated by Euresist Network, 22 primary universities, hospitals and ICT research centres are already working to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics. With the support of strong immuno-virological and artificial intelligence components, the study will take advantage of large hospital patients, vaccinated healthcare workers and schools’ cohorts in Europe, Kenya, Mexico, Russia and Vietnam to find an answer to urgent issues related to science and society.
27-30 October 2021
The Poster "Declining incidence of HIV multidrug resistance in Europe" has won the Best Poster Award at the 18th European AIDS Conference held Online & London, United Kingdom.
CARE HIV-TB-HCV: EU-Russia cooperation results
Online conference - June 15 2021, 9:00 – 16:00 CEST
The online meeting organised by the CARE Consortium had the objective to present and discuss outcomes and findings from CARE Common Action and other projects and initiatives in the frame of recent collaborative research in the WHO European Region.
It has seen the participation of CARE, ARREST-TB, CARE External Scientific Advisory Board, CARE External Ethics Review Board, Russian experts, NDPHS, Russian Ministry of Health, Russian Ministry of Science and Higher Education, EC, EU Delegation to the Russian Federation.
1st April 2021 https://vimeo.com/event/832587
The marginal role of schools as a center for spreading the infection, when the necessary containment measures are adopted, is now demonstrated by most of the scientific literature. However, doubts remain in society and in the political world, especially as regards high schools and relatively to the spread of viral variants.
On the contrary, the costs of closure are not yet fully known and are still likely to be underestimated.
The webinar sponsored by EuResist Network will support the scientific discussion on these themes while involving both the civil society and the political institutions.
With the participation of scientists as Antonella D'arminio Monforte, Sara Gandini, Daniele Novara, of associations as Save the Children, AcrionAid, ForumDD, of members of the Italian Parliament and of the Minister for Equal Opportunities and the Family Elena Bonetti.
.png)
Coordinated by Euresist Network, 25 primary universities, hospitals and ICT research centres are collaborating to provide robust, data driven evidence to deal with SARS-CoV-2 variants and COVID-19 epidemics.
How do SARS-COV-2 variants, coupled with other factors, influence the clinical course of COVID-19? Is there any vaccine or test escape related to variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?
With the support of strong immuno-virological and artificial intelligence components, the study will take advantage of large hospital patients, vaccinated healthcare workers and schools’ cohorts in Europe, Kenya, Mexico, Russia and Vietnam to find an answer to urgent issues related to science and society....
CARE
CARE (Common Action against HIV/TB/HCV across the Regions of Europe) aims at analysing and addressing the human immunodeficiency virus (HIV), tuberculosis (TB) and hepatitis C (HCV) epidemics across Europe and Russia, by establishing new networks and consolidating previous cooperative actions between the European Union and the Russian Federation.
MDR
The MDR project (HIV multidrug resistance pathways in the EuResist Integrated DataBase) aims at estimating the prevalence and trend over time of MDR (multidrug resistance) in HIV patients, using descriptive statistics, retaining high value because of the large sample size and wide representativeness of the EIDB.
The INTEGRATE project aims at building and maintaining a large, curated collection of virological and clinical data to increase scientific knowledge on resistance to integrase strand transfer inhibitors (InSTI) and on the most appropriate use of this class of antiretroviral agents.
Ciao Andrea.
On Feb 4th 2019, our great friend and EuResister Andrea De Luca lost his life in a horrible car accident, at the age of 55.
One year has passed and still we miss him with incredulity and sorrow.
Among many other projects, Andrea joined EuResist as a key leader soon after its launch, devoting his energy, commitment and capability to the success of the Network. He was an extra lively, smart, passionate, and positive person, always ready to help and take new tasks.
His loss is a huge loss for us, for his patients, for his beloved ones, for the international research community.
Ciao Andrea, we'll always miss you.